Canopy Growth Inks Partnership with Craft Queen Martha Stewart


 
 
03:42 03/04/2019

Canadian marijuana producer Canopy Growth CGC  has recently announced that Martha Stewart will be joining the company as an adviser to help develop products derived from cannabis for people and animals.

Stewart is teaming up with the major Canadian marijuana and hemp producer to develop a line of CBD products.

According to the announcement, Stewart will be advising the company as it develops this new line, first starting with animal health products.

“I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,” Stewart said.

She added, "I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets.”

CEO of Canopy Growth, Bruce Linton, remarked, "As soon as you hear the name Martha , you know exactly who we’re talking about. Martha is one of a kind and I am so excited to be able to work alongside this icon to sharpen our CBD product offerings across categories from human to animal.”

Canopy Growth not too long ago also announced that it had received a license from New York state to process and produce hemp. The license will allow the company to develop products that contain CBD. CBD is a non-psychoactive compound of marijuana that has been said to alleviate many medical conditions.

President Trump signed the Farm Bill this past December which legalized hemp and hemp-derived CBD products.

Canopy Growth also just announced a transformative clinical research partnership that will investigate the efficacy of cannabinoids as an integral part of a novel treatment for post-concussion neurological diseases in former NHL players.

The company's press release states that "researchers estimate that between 1.6 and 3.8 million athletes suffer from a sports-related concussion each year*. Ten to 15 percent of these athletes will go on to develop chronic post-concussion symptoms that can affect their ability to function."
“NHL alumni gave everything they had during their careers, but the physical consequences after they hang up their skates can be devastating for both players and their loved ones for the rest of their lives,” said Glenn Healy, Executive Director of the NHLAA. “This study offers alumni the promise of help and hope, and we are excited to participate in what could become a true game-changer in allowing these professional athletes to finish strong.”

We have seen the debilitating effects of chronic repeated head injuries on the lives of patients and their families,” said Dr. Amin Kassam, Founder and CEO of NEEKA Health Canada. “Our team is excited to partner with Canopy Growth, a global leader in cannabis science and the NHL Alumni Association, a committed organization to its players, to demonstrate the immense and unexplored opportunity in cannabis-based remedies, particularly when synergized by novel treatment paradigms such as digital mental health and behavioral therapy.”

“This complex and multidimensional study will give us an unprecedented understanding of the interaction between cannabidiol (CBD) and the brains and behaviours of former NHL players living with post-concussion symptoms,” said Dr. Mark Ware, Chief Medical Officer at Canopy Growth. “We thank the members of the NHLAA whose willingness to join this unique research partnership speaks to the need for alternative medical treatments to treat the long-term and often devastating effects of concussions.”

 




This article has been provided by a Chasing Markets contributor. All content submitted by this author represent their personal opinions, and should be considered as such for entertainment purpose only. All opinions expressed are those of the writer, and may not necessarily represent fact, opinions, or bias of Chasing Markets.
Most Read